Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Billings: Nov 28, 2012

Premium

Paul Billings has been appointed to Trovagene's scientific advisory board. Billings is currently chief medical officer at Life Technologies and serves on the scientific advisory board of the US Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and the National Academy of Sciences Institute of Medicine's roundtable on genomics. Previously, he served as director and chief scientific officer of El Camino Hospital and senior vice president for corporate development at Laboratory Corporation of America. He holds an MD from Harvard Medical School and a PhD in immunology, also from Harvard.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.